Pharmacotherapeutic considerations for psychiatric disorders

Depression

Emile Risby, Deane Donnigan, Charles Nemeroff

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Major depression is a psychiatric disorder associated with significant morbidity, lost productivity, and high health care utilization costs. Its pharmacologic treatment has changed during the past decade due to the development of new agents. While the newer antidepressants do not appear to offer greater efficacy over the older antidepressants, they are associated with fewer side effects and have fewer dietary and medical prescribing restrictions and contraindications. This article reviews the formulary considerations-efficacy and side effect profiles, pharmacoeconomic considerations, dosing and administration-for each pharmacologic option available to treat depression.

Original languageEnglish
JournalFormulary
Volume32
Issue number1
StatePublished - Feb 1 1997
Externally publishedYes

Fingerprint

Antidepressive Agents
Psychiatry
Patient Acceptance of Health Care
Formularies
Pharmaceutical Economics
Health Care Costs
Morbidity

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Pharmacotherapeutic considerations for psychiatric disorders : Depression. / Risby, Emile; Donnigan, Deane; Nemeroff, Charles.

In: Formulary, Vol. 32, No. 1, 01.02.1997.

Research output: Contribution to journalArticle

@article{d88987d3d71849eaa2df85efd4ee22c9,
title = "Pharmacotherapeutic considerations for psychiatric disorders: Depression",
abstract = "Major depression is a psychiatric disorder associated with significant morbidity, lost productivity, and high health care utilization costs. Its pharmacologic treatment has changed during the past decade due to the development of new agents. While the newer antidepressants do not appear to offer greater efficacy over the older antidepressants, they are associated with fewer side effects and have fewer dietary and medical prescribing restrictions and contraindications. This article reviews the formulary considerations-efficacy and side effect profiles, pharmacoeconomic considerations, dosing and administration-for each pharmacologic option available to treat depression.",
author = "Emile Risby and Deane Donnigan and Charles Nemeroff",
year = "1997",
month = "2",
day = "1",
language = "English",
volume = "32",
journal = "Formulary",
issn = "0098-6909",
publisher = "Advanstar Communications",
number = "1",

}

TY - JOUR

T1 - Pharmacotherapeutic considerations for psychiatric disorders

T2 - Depression

AU - Risby, Emile

AU - Donnigan, Deane

AU - Nemeroff, Charles

PY - 1997/2/1

Y1 - 1997/2/1

N2 - Major depression is a psychiatric disorder associated with significant morbidity, lost productivity, and high health care utilization costs. Its pharmacologic treatment has changed during the past decade due to the development of new agents. While the newer antidepressants do not appear to offer greater efficacy over the older antidepressants, they are associated with fewer side effects and have fewer dietary and medical prescribing restrictions and contraindications. This article reviews the formulary considerations-efficacy and side effect profiles, pharmacoeconomic considerations, dosing and administration-for each pharmacologic option available to treat depression.

AB - Major depression is a psychiatric disorder associated with significant morbidity, lost productivity, and high health care utilization costs. Its pharmacologic treatment has changed during the past decade due to the development of new agents. While the newer antidepressants do not appear to offer greater efficacy over the older antidepressants, they are associated with fewer side effects and have fewer dietary and medical prescribing restrictions and contraindications. This article reviews the formulary considerations-efficacy and side effect profiles, pharmacoeconomic considerations, dosing and administration-for each pharmacologic option available to treat depression.

UR - http://www.scopus.com/inward/record.url?scp=15144357657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15144357657&partnerID=8YFLogxK

M3 - Article

VL - 32

JO - Formulary

JF - Formulary

SN - 0098-6909

IS - 1

ER -